Detection of Influenza A/H1N1-Specific Human IgG-Secreting B Cells in Older Adults by ELISPOT Assay
- 1 March 2014
- journal article
- research article
- Published by SAGE Publications in Viral Immunology
- Vol. 27 (2) , 32-38
Abstract
B cells play an important role in humoral immunity and antibody production. Use of a B cell ELISPOT assay to quantify antigen-specific B cells can assist other assays to achieve a more complete profile of the humoral immune response after vaccination. We utilized a B cell ELISPOT assay to measure the number of influenza A/H1N1-specific B cells at key timepoints after seasonal influenza vaccination in 106 older adults (50–74 years of age). Blood was drawn from these subjects on Day 0, Day 3, Day 28, and Day 75 after vaccination to represent baseline, early, peak, and late response, respectively, of influenza A/H1N1-specific B cells. A significant increase in A/H1N1-specific B cells (median 36 spot-forming units/SFUs per 200,000 cells, pp<0.0001) by Day 75, but not to baseline level. These data suggest that the B cell ELISPOT can be used to profile and monitor the humoral immune responses in older subjects after influenza vaccination, and serve as an immune signature marker.Keywords
This publication has 34 references indexed in Scilit:
- Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cellsProceedings of the National Academy of Sciences, 2012
- The unmet need in the elderly: How immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccinesVaccine, 2012
- Associations Between Demographic Variables and Multiple Measles-Specific Innate and Cell-Mediated Immune Responses After Measles VaccinationViral Immunology, 2012
- Targeting B cell responses in universal influenza vaccine designTrends in Immunology, 2011
- Systems biology of vaccination for seasonal influenza in humansNature Immunology, 2011
- B cell responses to H5 influenza HA in human subjects vaccinated with a drifted variantVaccine, 2010
- Influenza vaccines provide diminished protection but are cost‐saving in older adultsJournal of Internal Medicine, 2010
- Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adultsVaccine, 2009
- Rapid cloning of high-affinity human monoclonal antibodies against influenza virusNature, 2008
- Hemagglutinin (HA) Proteins from H1 and H3 Serotypes of Influenza A Viruses Require Different Antigen Designs for the Induction of Optimal Protective Antibody Responses as Studied by Codon-Optimized HA DNA VaccinesJournal of Virology, 2006